Great ideas are the foundation of science, but funding makes great ideas become realities and a monopoly on funding hurts science. UPDATE: NIH data backs up our conclusions: overfunding wastes precious resources–give the money to smaller labs. Arguably the key driver of the exciting progress in stem cell research is funding. With the stakes so […]
Stem cell monopoly: do not pass go, do not collect $200,000 Read More »
It has been a rollercoaster few months between the anti-hESC court cases as well as Geron and Advanced Cell Technology (ACT) receiving the OK from the FDA to proceed with initial clinical trials of stem cell treatments. It’s OK to be excited about the clinical trials and I for one am, but we have to
Challenges translating stem cell treatments to patients Read More »
Cancer is a class of diseases that are intimately linked to stem cells. In fact, I would go so far as to call some types of cancer cells and stem cells, cousins. This concept, of a tight relationship between stem and cancer cells, is under intense investigation but at the same time it is something
Disease Focus Series: Cancer Read More »
This is the first post in a series focusing on stem cell advances related to specific diseases. Today we discuss Huntington’s Disease and a paper that came out yesterday in the journal Neuron that provides some significant insight into the mechanisms behind the disease. It is entitled: Huntingtin Is Required for Mitotic Spindle Orientation and
Huntington’s Disease, a major new finding Read More »